MOR1 expression in gastric cancer: a biomarker associated with poor outcome. - Wikidata - wikimedia - TriplyDB

MOR1 expression in gastric cancer: a biomarker associated with poor outcome.

MOR1 expression in gastric cancer: a biomarker associated with poor outcome.

http://www.wikidata.org/entity/Q37700635

about

Translational Research and Plasma Proteomic in Cancer.Methadone as a "Tumor Theralgesic" against Cancer.

P2860

Q38610869-392DEBBB-27E5-4FC1-B365-0A5D69FEA003 Q47150971-7CEDF430-8CF4-48E6-8361-3ACE8E3A6167

P2860

MOR1 expression in gastric cancer: a biomarker associated with poor outcome.

http://www.wikidata.org/entity/Q37700635

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 December 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

MOR1 expression in gastric cancer: a biomarker associated with poor outcome.

@en

MOR1 expression in gastric cancer: a biomarker associated with poor outcome.

@nl

type

label

MOR1 expression in gastric cancer: a biomarker associated with poor outcome.

@en

MOR1 expression in gastric cancer: a biomarker associated with poor outcome.

@nl

prefLabel

MOR1 expression in gastric cancer: a biomarker associated with poor outcome.

@en

MOR1 expression in gastric cancer: a biomarker associated with poor outcome.

@nl

P1433

Q37700635-F6D631BF-7907-4998-871A-1CD52920094B

P1476

Q37700635-8954FE25-A784-439B-BA0E-CD83AAA20217

P2093

Q37700635-06E74811-BC5A-4B85-AA71-3BBC1A1A7BA6

Q37700635-20F739A0-5123-4B40-ABA0-F5E1677576DB

Q37700635-2D4874DD-9155-48EC-81AA-F0D8FEC749C6

Q37700635-3F3206BD-347B-4DA1-A5A6-87DDCFE4E623

Q37700635-89DAB082-D10D-4ECA-9076-E5761DFB4692

Q37700635-B349D4D6-22F7-4405-AE77-F3FEAEF772FD

Q37700635-CECDA631-B608-4870-B66F-9F3DAA2CD9C7

Q37700635-D080DC47-653C-4658-8829-51D13EF4A795

P2860

Q37700635-04A51523-32C3-4C0C-AABC-C2B2176754EF

Q37700635-0AA1A5F8-3E9C-4662-8096-091598A53D87

Q37700635-0BD52E2F-6948-4DA2-9A30-526870774B08

Q37700635-0F3CE32D-0562-4FC6-B495-9941C696A184

Q37700635-340A0949-0430-4054-9EBC-57330764A000

Q37700635-3615C576-6439-4476-99BD-A4D473BDB1F7

Q37700635-3B6B10DD-8CB3-4ABC-84E3-09F790AF421E

Q37700635-3FDE5E5A-9BEF-4149-A955-E4CC26462C56

Q37700635-41EEEDB9-D594-436A-9837-86A7281E0BA8

Q37700635-42409ADE-845A-4524-BE87-610244A48DB7

P304

Q37700635-15EC8594-6E71-4F54-8389-E68E3C08DD29

P31

Q37700635-384AEC61-0277-4B63-876E-26FA02D0B40D

P356

Q37700635-03C5A137-FF16-4E23-B93A-2BA826808401

P407

Q37700635-34907AFF-60F5-463E-964E-4AAB157AB8E3

P433

Q37700635-21638242-9E1D-4871-81C6-4DD2F1EA57A8

P478

Q37700635-375A274A-F795-4E2E-A173-C76DB45B86EA

P577

Q37700635-41513C49-2CAF-44D1-94CE-D403C855F004

P698

Q37700635-8750DA7B-A281-444B-978D-202A7524A800

P921

Q37700635-E06A9EA5-4E00-4D76-AB84-6E6BCF7BB7A5

P932

Q37700635-10FE3176-E6C1-42D3-9B41-5DB252699027

P356

P1433

Clinical and Translational Science

P1476

MOR1 expression in gastric cancer: a biomarker associated with poor outcome.

@en

P2093

Fei Zhou

http://www.w3.org/2001/XMLSchema#string

Jing Lv

http://www.w3.org/2001/XMLSchema#string

Li-kun Zhuang

http://www.w3.org/2001/XMLSchema#string

Lu Yue

http://www.w3.org/2001/XMLSchema#string

Ru-yong Yao

http://www.w3.org/2001/XMLSchema#string

Wei-wei Qi

http://www.w3.org/2001/XMLSchema#string

Wen-sheng Qiu

http://www.w3.org/2001/XMLSchema#string

Ya-sai Yao

http://www.w3.org/2001/XMLSchema#string

P2860

Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesis

Morphine promotes rapid, arrestin-dependent endocytosis of mu-opioid receptors in striatal neurons

Methylnaltrexone potentiates the anti-angiogenic effects of mTOR inhibitors

Increased μ-opioid receptor expression in metastatic lung cancer

Opioids for cancer pain: the challenge of optimizing treatment.

Opioid pharmacology.

Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer.

The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation

Opioid peptides in cancer.

The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection.

P304

137-142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CTS.12246

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25441763

http://www.w3.org/2001/XMLSchema#string

P921

P932

5350983

http://www.w3.org/2001/XMLSchema#string